Onkos Surgical’s My3D® System: FDA Clears Breakthrough in Personalized 3D Printed Pelvic Reconstruction

In a significant advancement for orthopedic medicine, Onkos Surgical, a leading orthopedic company renowned for its innovative solutions, recently announced that its My3D® Personalized Pelvic Reconstruction system has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). This landmark approval paves the way for a transformative approach to complex pelvic surgeries, leveraging cutting-edge 3D printing technologies to create custom-made medical implants, precision surgical instruments, and highly detailed anatomical models. Based in New Jersey, Onkos Surgical has dedicated itself to developing innovative solutions that address severe physical limitations and malfunctions, and the My3D system exemplifies this commitment by offering unparalleled customization for the intricate reconstruction of multiple parts of the human pelvis.

The medical sector has witnessed a profound paradigm shift since the integration of additive manufacturing (AM) into clinical practice. This revolutionary technology has unlocked a wealth of possibilities, empowering healthcare professionals to introduce novel treatment modalities that offer renewed hope to patients previously facing limited options. Among the diverse applications of AM in medicine, the 3D printing of prosthetics and implants stands out for its profoundly positive impact on individuals suffering from various physical deficits. The Onkos My3D® Personalized Pelvic Reconstruction system represents a particularly promising new solution within this sphere, poised to dramatically improve the quality of life for those afflicted by challenging issues in the pelvic region. With the rigorous evaluation and subsequent greenlight from the FDA, this advanced system is now ready for clinical deployment, bringing highly personalized treatment options closer to patients who need them most, ensuring both safety and efficacy.

The Power of Personalization: Custom Implants for Complex Pelvic Conditions

At its core, the MY3D Personalized Pelvic Reconstruction (PPR) system is meticulously designed to facilitate the 3D printing of patient-specific implants. Its primary focus lies in supporting both acetabular and advanced reconstruction procedures across various critical regions of the pelvis. The inherent capabilities of additive manufacturing technologies are central to this innovation, enabling implants to be meticulously designed and produced with unique, patient-specific anatomical features. This level of customization marks a significant departure from traditional implant manufacturing, offering a truly tailored approach to complex orthopedic challenges.

Historically, conventionally produced implants have often presented challenges and led to complications. These implants are typically mass-produced in a range of pre-determined sizes, designed to accommodate a general spectrum of body types. While these standard sizes may offer a reasonable fit for many patients to a certain degree, the profound uniqueness of every individual’s anatomy, particularly within the highly complex and irregular structure of the pelvis, can frequently result in suboptimal fitting. A poor fit can lead to a host of problems, including implant loosening, chronic pain, reduced range of motion, increased risk of infection, and even the need for revision surgery – a procedure that is often more complicated and carries higher risks than the initial operation. The pelvic region, being central to weight-bearing, locomotion, and housing vital organs, demands exceptional precision in reconstruction to ensure optimal function and long-term stability.

In stark contrast, the 3D-printed alternatives offered by the My3D system are truly tailor-made. Each implant is meticulously crafted to match the patient’s exact anatomical contours, ensuring an unparalleled and precise fit. This bespoke approach minimizes the potential for complications associated with ill-fitting standard implants, promotes better biomechanical integration, and ultimately aims to enhance long-term patient outcomes. The ability to create such intricate, customized geometries is a direct benefit of advanced 3D printing technologies like Selective Laser Melting (SLM) or Electron Beam Melting (EBM), which are often employed for metallic implants (e.g., medical-grade titanium). These methods allow for the creation of porous structures within the implant, encouraging natural bone ingrowth (osseointegration) and significantly improving the implant’s stability and longevity within the body.

Streamlining Surgical Planning with the uDesign Digital Ecosystem

Integral to the service provided by Onkos Surgical and the My3D system is access to its proprietary uDesign digital ecosystem. This sophisticated, cloud-based portal is meticulously engineered to be HIPAA-compliant, ensuring the utmost security and privacy for sensitive patient data. The uDesign platform revolutionizes the surgical workflow by allowing surgeons to securely transmit patient images – such as high-resolution CT or MRI scans – to Onkos. Once received, Onkos’s expert team utilizes these anatomical images to generate highly accurate, three-dimensional digital models of the patient’s specific pelvic anatomy and pathology. These detailed 3D models then become invaluable tools for virtual surgical planning sessions. Surgeons can collaboratively work with Onkos engineers to pre-plan every aspect of the surgery, from precise implant placement and optimal orientation to surgical approaches and potential osteotomies (bone cuts). This virtual rehearsal not only refines the surgical strategy but also allows for the identification and mitigation of potential challenges before the actual procedure, leading to more predictable, efficient, and ultimately successful outcomes in the operating room. This pre-operative visualization significantly reduces surprises during surgery, potentially shortening operating times and improving patient safety.

Clinical Endorsement and the Future of Orthopedic Treatment

The positive reception from the orthopedic community underscores the profound impact and transformative potential of the My3D system. Matthew Seidel, MD, an esteemed orthopedic surgeon with HonorHealth Orthopedics in Scottsdale, AZ, shared his enthusiastic anticipation for utilizing the system. Dr. Seidel stated, “This offering from Onkos Surgical will greatly advance how I and my colleagues treat these patients. Patients with these conditions of the pelvis have many clinical challenges. Historically, our implant options are mass-produced and may not be best suited for the individuality that each patient requires. With this platform, Onkos has developed a process that allows me to virtually plan the surgery in advance and deliver a patient-specific implant and instruments in a matter of weeks. It changes the way I can treat my patients.” His statement highlights several critical benefits: the significant leap forward in treatment methodologies, the inherent limitations of ‘one-size-fits-all’ mass-produced implants, and the revolutionary efficiency of virtual planning coupled with rapid delivery of custom solutions. The ability to receive a patient-specific implant and corresponding instruments within weeks, rather than months, is a game-changer, improving patient access to advanced care and potentially reducing waiting times for critical surgeries, ultimately leading to better and more timely patient care.

While the specific details regarding the exact processes, underlying additive manufacturing technologies, and materials utilized in the My3D system have not yet been fully disclosed by Onkos Surgical, the announcement of its FDA 510(k) clearance itself represents an immensely important milestone for the entire orthopedic industry. This clearance signifies that the My3D system has been rigorously reviewed by the FDA and found to be substantially equivalent to existing legally marketed devices, demonstrating its safety and effectiveness for its intended use. Such regulatory approval is a critical step, instilling confidence in both surgeons and patients regarding the reliability and clinical utility of these advanced 3D-printed solutions. The FDA’s endorsement paves the way for broader adoption and will undoubtedly prove beneficial for countless patients worldwide who suffer from complex pelvic pathologies, offering them new avenues for improved mobility and quality of life.

Patrick Treacy, Co-Founder and CEO of Onkos Surgical, aptly summarized the company’s achievement, stating, “This clearance is a major milestone for Onkos Surgical as we continue to leverage our experience and expertise in 3D planning and printing to optimize patient specific solutions for complex orthopaedic conditions.” This statement underscores Onkos Surgical’s strategic vision: to remain at the forefront of personalized orthopedic care, continuously pushing the boundaries of what is possible through the intelligent integration of 3D technology. The company’s commitment to innovation is clear, and the My3D system is a testament to their dedication to improving patient outcomes for the most challenging cases, solidifying their position as leaders in advanced orthopedic solutions. To delve deeper into Onkos Surgical’s pioneering work and explore their comprehensive range of orthopedic solutions, interested parties are encouraged to visit their official website, accessible HERE.

We value your insights! What are your thoughts on the FDA clearance of Onkos Surgical’s groundbreaking My3D® system and its implications for the future of orthopedic surgery? Let us know your perspective in a comment below or join the conversation on our LinkedIn, Facebook, and Twitter pages! To stay informed about the latest breakthroughs and developments in the dynamic world of 3D printing, don’t forget to sign up for our free weekly Newsletter here, delivering the most relevant news straight to your inbox! Additionally, you can find an extensive collection of our videos showcasing additive manufacturing innovations on our YouTube channel.

*All Photo Credits: Onkos Surgical